Q32 Bio Inc. (QTTB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 10M 20M 30M Q1 '18: 1.1M Q2 '18: 1.4M Q3 '18: 1.6M Q4 '18: 1.2M Q1 '19: 270K Q2 '19: 392K Q3 '19: 441K Q4 '19: 563K Q1 '20: 588K Q2 '20: 567K Q3 '20: 567K Q4 '20: 980K Q1 '21: 29.3M Q2 '21: 2.2M Q3 '21: 1.7M Q4 '21: 802K Q1 '22: 802K Q2 '22: 802K Q3 '22: 802K Q4 '22: 802K Q1 '23: 802K Q2 '23: 354K Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '17: -4.7M Q2 '17: -6M Q3 '17: -6.7M Q4 '17: -12.3M Q1 '18: -10.7M Q2 '18: -13.4M Q3 '18: -15.6M Q4 '18: -20.2M Q1 '19: -25.1M Q2 '19: -28M Q3 '19: -31.3M Q4 '19: -25.6M Q1 '20: -36.5M Q2 '20: -35.7M Q3 '20: -28.3M Q4 '20: -29.8M Q1 '21: -1.1M Q2 '21: -30.6M Q3 '21: -30.7M Q4 '21: -33.6M Q1 '22: -37.6M Q2 '22: -28.3M Q3 '22: -32.9M Q4 '22: -34.5M Q1 '23: -7.4M Q2 '23: -7.3M Q3 '23: -7.8M Q4 '23: -25.8M Q1 '24: -14.8M Q2 '24: -17.9M Q3 '24: -18.8M Q4 '24: -14.5M Q1 '25: -12.2M Q2 '25: -9.2M Q3 '25: -7.6M Q1 '26: -7.7M Q2 '26: -9.1M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q2 '26

Net Income Quarterly

-70M -35M 0 35M 70M 105M Q1 '17: -5.6M Q2 '17: -6M Q3 '17: -6.5M Q4 '17: -11.9M Q1 '18: -10.2M Q2 '18: -12.4M Q3 '18: -14.1M Q4 '18: -18.8M Q1 '19: -23.9M Q2 '19: -26.3M Q3 '19: -29.6M Q4 '19: -24.2M Q1 '20: -35.3M Q2 '20: -35.3M Q3 '20: -28.2M Q4 '20: -29.8M Q1 '21: -1.1M Q2 '21: -30.5M Q3 '21: -30.6M Q4 '21: -33.6M Q1 '22: 92.1M Q2 '22: -29.1M Q3 '22: -33.7M Q4 '22: -34.3M Q1 '23: -6.8M Q2 '23: -5.8M Q3 '23: -14M Q4 '23: -27.1M Q1 '24: 1M Q2 '24: -17M Q3 '24: -17.6M Q4 '24: -14.2M Q1 '25: -11M Q2 '25: -9.5M Q3 '25: -7.4M Q4 '25: 57.7M Q1 '26: -7.6M Q2 '26: -8.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '17: -4.5M Q3 '17: -5.4M Q1 '18: -11M Q2 '18: -9.7M Q3 '18: -13.7M Q4 '18: -8.1M Q1 '19: -17.9M Q2 '19: -21.7M Q3 '19: -25.5M Q4 '19: -26.3M Q1 '20: -25.8M Q2 '20: -28M Q3 '20: -28.9M Q4 '20: -11.6M Q1 '21: -29.8M Q2 '21: -24.1M Q3 '21: -25.4M Q4 '21: -30.4M Q1 '22: -30.7M Q2 '22: -30.8M Q3 '22: -24.9M Q4 '22: -27.2M Q1 '23: -12.5M Q2 '23: -11.4M Q3 '23: 15.9M Q4 '23: -10.7M Q1 '24: -14.6M Q2 '24: -22.2M Q3 '24: -19.5M Q4 '24: -11.4M Q1 '25: -12.5M Q2 '25: -10.7M Q3 '25: -4.2M Q4 '25: -6.2M Q1 '26: -6.3M Q2 '26: -3.1M Q1 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '17: -5.4M Q3 '17: -5.7M Q1 '18: -12.1M Q2 '18: -12.9M Q3 '18: -18.5M Q4 '18: -24M Q1 '19: -28.3M Q2 '19: -27.6M Q3 '19: -27.2M Q4 '19: -30.1M Q1 '20: -27.9M Q2 '20: -28.6M Q3 '20: -29M Q4 '20: -12.6M Q1 '21: -30.6M Q2 '21: -24.9M Q3 '21: -25.9M Q4 '21: -30.8M Q1 '22: -31.8M Q2 '22: -31M Q3 '22: -24.9M Q4 '22: -27.2M Q1 '23: -12.5M Q2 '23: -11.4M Q3 '23: 15.9M Q4 '23: -10.7M Q1 '24: -14.6M Q2 '24: -22.2M Q3 '24: -19.6M Q4 '24: -11.4M Q3 '25: -4.2M Q4 '25: -6.2M Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '21: 50.4M Q2 '21: 56.5M Q3 '21: 57.1M Q1 '22: 57.9M Q2 '22: 57.4M Q3 '22: 57.4M Q1 '23: 344.6K Q2 '23: 347.9K Q3 '23: 346.3K Q1 '24: 2.3M Q2 '24: 12M Q3 '24: 12.1M Q1 '25: 12.2M Q2 '25: 12.2M Q3 '25: 12.2M Q1 '26: 14.1M Q2 '26: 20.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-180.00 -120.00 -60.00 0.00 60.00 120.00 180.00 Q4 '17: -12.85 Q1 '18: -14.15 Q2 '18: -11.88 Q3 '18: -9.48 Q4 '19: -2.47 Q1 '20: -2.61 Q2 '20: -2.78 Q3 '20: -2.73 Q4 '20: -2.79 Q1 '21: -2.03 Q2 '21: -1.79 Q3 '21: -1.71 Q4 '21: -1.69 Q1 '22: -0.08 Q2 '22: -0.05 Q3 '22: -0.10 Q4 '22: -0.09 Q1 '23: -21.52 Q2 '23: -37.70 Q3 '23: -77.63 Q4 '23: -154.20 Q1 '25: -4.76 Q2 '25: -4.12 Q3 '25: -3.26 Q4 '25: 2.43 Q1 '26: 2.79 Q2 '26: 3.13 Q2 '18 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.